Pulmonologists are at the forefront of detecting and managing lung disease - and now, artificial intelligence (AI) is redefining what’s possible in early detection and workflow efficiency.

The Temple Lung Center has become the first pulmonary program in the nation to integrate AI into routine lung screening, using AI software as a core diagnostic tool that supports early detection, multidisciplinary review, and streamlined patient care pathways.

Through the Temple Healthy Chest Initiative’s dedicated lung screening program, every low-dose computed tomography (LDCT) scan is now processed using an AI-powered analytics platform designed to detect and flag abnormalities associated with lung nodules, COPD, coronary artery calcification, and early-stage lung cancer. By embedding this technology into a clinical workflow, Temple ensures that no scan goes under-reviewed and no subtle disease is overlooked.

Temple’s AI-driven model not only advances patient care, it redefines what's possible in preventive pulmonary medicine. By combining breakthrough precision technology with a collaborative multidisciplinary team, Temple is setting a new national standard for comprehensive, AI-supported screening and disease management.

To learn more about how the Temple Lung Center is leveraging AI-powered software to improve clinical workflows and patient outcomes, register for a FREE webinar on August 1st, 2025 from 1:30pm-3:00pm EST.

LDCT+ - Leveraging AI and Spirometry for Better Patient Outcomes

This past year, the Temple Lung Center’s dedicated screening program surpassed 10,000 patient lung cancer screenings. As the program continues to scale, it has introduced spirometry testing alongside LDCT scans to better detect undiagnosed COPD and airflow obstruction, leading to earlier treatment and better outcomes for patients. These tests are bundled into a single patient appointment for ease of access.

The updated GOLD 2023 Guidelines advise the inclusion of spirometry as a standard of care for accurate measurement of lung function, as evidence is emerging this leads to more appropriate treatment for COPD patients.

Learn more about how the Temple Lung Center is pioneering new approaches that enhance lung health and improve patient outcomes around the world.